Genetic modification will make slow headway in China
The state is promoting biotechnology with greater energy, but faces mounting resistance
You must be signed in to read this analysis
In this article
- New momentum
- Public hostility
- Syngenta merger
- Supervision
- Commercialisation
- Turf wars
- Going global?
- Import liberalisation unlikely
What is this?
This article is from the Oxford Analytica Daily Brief, which analyses geopolitical, economic, social, business and industrial developments on a global and regional basis, providing clients with timely, authoritative analysis every business day of the year. Find out more about the Oxford Analytica Daily Brief, or request a trial.
_350.jpg "Corn plants in Syngenta Biotech Center, Beijing (Reuters/Kim Kyung)")